Fux B, Ferreira A, Cassali G d, Tafuri W L, Vitor R W
Departamento de Parasitologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, 31270-901, Brasil.
Mem Inst Oswaldo Cruz. 2000 Jan-Feb;95(1):121-6. doi: 10.1590/s0074-02762000000100020.
In a study of congenital transmission during acute infection of Toxoplasma gondii, 23 pregnant Balb/c mice were inoculated orally with two cysts each of the P strain. Eight mice were inoculated 6-11 days after becoming pregnant (Group 1). Eight mice inoculated on the 10th-15th day of pregnancy (Group 2) were treated with 100 mg/kg/day of minocycline 48 h after inoculation. Seven mice inoculated on the 10th-15th day of pregnancy were not treated and served as a control (Group 3). Congenital transmission was evaluated through direct examination of the brains of the pups or by bioassay and serologic tests. Congenital transmission was observed in 20 (60.6%) of the 33 pups of Group 1, in one (3.6%) of the 28 pups of Group 2, and in 13 (54.2%) of the 24 pups of Group 3. Forty-nine Balb/c mice were examined in the study of congenital transmission of T. gondii during chronic infection. The females showed reproductive problems during this phase of infection. It was observed accentuated hypertrophy of the endometrium and myometrium. Only two of the females gave birth. Our results demonstrate that Balb/c mice with acute toxoplasmosis can be used as a model for studies of congenital T. gondii infection. Our observations indicate the potential of this model for testing new chemotherapeutic agents against congenital toxoplasmosis.
在一项关于刚地弓形虫急性感染期间先天性传播的研究中,23只怀孕的Balb/c小鼠经口接种了P株的两个包囊。8只小鼠在怀孕6 - 11天后接种(第1组)。8只在怀孕第10 - 15天接种的小鼠(第2组)在接种后48小时用100 mg/kg/天的米诺环素进行治疗。7只在怀孕第10 - 15天接种的小鼠未接受治疗,作为对照(第3组)。通过直接检查幼崽的大脑或通过生物测定和血清学检测来评估先天性传播。在第1组的33只幼崽中有20只(60.6%)观察到先天性传播,第2组的28只幼崽中有1只(3.6%),第3组的24只幼崽中有13只(54.2%)。在慢性感染期间刚地弓形虫先天性传播的研究中检查了49只Balb/c小鼠。雌性小鼠在感染的这个阶段出现生殖问题。观察到子宫内膜和子宫肌层明显肥大。只有两只雌性小鼠产仔。我们的结果表明,患有急性弓形虫病的Balb/c小鼠可用作先天性刚地弓形虫感染研究的模型。我们的观察结果表明该模型在测试针对先天性弓形虫病的新化疗药物方面的潜力。